Accessibility Menu
 
Biote logo

Biote

(NASDAQ) BTMD

Current Price$2.19
Market Cap$71.14M
Since IPO (2021)-78%
5 Year-78%
1 Year-33%
1 Month+64%

Biote Financials at a Glance

Market Cap

$71.14M

Revenue (TTM)

$192.22M

Net Income (TTM)

$27.05M

EPS (TTM)

$0.76

P/E Ratio

2.93

Dividend

$0.00

Beta (Volatility)

0.54 (Low)

Price

$2.19

Volume

7,120

Open

$2.25

Previous Close

$2.19

Daily Range

$2.18 - $2.26

52-Week Range

$1.27 - $4.75

BTMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biote

Industry

Pharmaceuticals

Employees

223

CEO

Bret Christensen, MBA

Headquarters

Irving, TX 75038, US

BTMD Financials

Key Financial Metrics (TTM)

Gross Margin

71%

Operating Margin

18%

Net Income Margin

14%

Return on Equity

0%

Return on Capital

57%

Return on Assets

25%

Earnings Yield

34.13%

Dividend Yield

0.00%

Payout Ratio

6.39%

Stock Overview

Market Cap

$71.14M

Shares Outstanding

32.05M

Volume

7.12K

Avg. Volume

242.54K

Financials (TTM)

Gross Profit

$137.36M

Operating Income

$35.55M

EBITDA

$39.22M

Operating Cash Flow

$35.19M

Capital Expenditure

$5.01M

Free Cash Flow

$30.18M

Cash & ST Invst.

$24.12M

Total Debt

$109.92M

Biote Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$46.41M

-6.9%

Gross Profit

$31.57M

-11.1%

Gross Margin

68.03%

N/A

Market Cap

$71.14M

N/A

Market Cap/Employee

$327.85K

N/A

Employees

217

N/A

Net Income

$1.95M

-47.2%

EBITDA

$3.97M

-226.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$85.80M

-20.0%

Accounts Receivable

$6.87M

-10.8%

Inventory

$19.06M

+28.4%

Long Term Debt

$103.08M

-1.0%

Short Term Debt

$6.84M

+1.0%

Return on Assets

25.13%

N/A

Return on Invested Capital

56.77%

N/A

Free Cash Flow

$6.49M

-42.5%

Operating Cash Flow

$7.57M

-38.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACTUActuate Therapeutics Inc
$3.00+2.04%
MCRBSeres Therapeutics, Inc.
$7.61+3.26%
INOInovio Pharmaceuticals, Inc.
$1.10-1.79%
SCLXScilex Holding Company
$10.58+0.57%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.05+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.68+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.33+0.03%
NIONio
$5.92-0.07%

Questions About BTMD

What is the current price of Biote?

Biote is trading at $2.19 per share.

What is the 52-week range for Biote?

Over the past 52 weeks, Biote has traded between $1.27 and $4.75.

How much debt does Biote have?

As of the most recent reporting period, Biote reported total debt of $128.42M.

How much cash does Biote have on hand?

Biote reported $24.12M in cash and cash equivalents in its most recent financial results.

What is Biote’s dividend yield?

Biote does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.